Literature DB >> 11260975

[Articular involvement in the course of primary hypogammaglobulinemia].

N Pipitone1, A Fioravanti, R Marcolongo, C Pitzalis.   

Abstract

The Authors describe the main features of the most common forms of primary hypogammaglobulinaemia (PH) focusing on the articular involvement. Patients with Bruton's agammaglobulinemia (BA) and common variable immune deficiency (CVID) are predisposed to develop septic arthritis (including arthritis due to atypical microorganisms such as mycoplasma), arthralgia and symmetrical (usually non-erosive) polyarthritis. In BA and CVID complicated by recurrent infections, amyloidosis, which may be itself a cause of arthropathy, can occur. In addition, patients with CVID and selective IgA deficiency show an increased prevalence of juvenile rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome and primary biliary cirrhosis, while patients with selective IgA deficiency are prone to developing seronegative spondylarthropathies, including ankylosing spondylitis. The mainstay of treatment for BA and CVID is replacement therapy with human immunoglobulins. Septic arthritis should be promptly treated with antibiotics, whereas other types of arthritis usually respond well to non-steroidal antiinflammatory medications. In contrast, the second line agents commonly used to treat rheumatoid arthritis do not appear to be beneficial in patients with PH-associated arthritis.

Entities:  

Mesh:

Year:  2001        PMID: 11260975

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  2 in total

1.  Secondary renal amyloidosis in a patient of pulmonary tuberculosis and common variable immunodeficiency.

Authors:  Manish R Balwani; Vivek B Kute; Pankaj R Shah; Pawan Wakhare; Hargovind L Trivedi
Journal:  J Nephropharmacol       Date:  2015-06-21

2.  A rare cause of secondary amyloidosis: common variable immunodeficiency disease.

Authors:  Ali Kemal Kadiroğlu; Yaşar Yıldırım; Zülfükar Yılmaz; Hasan Kayabaşı; Yahya Avcı; M Serdar Yıldırım; M Emin Yılmaz
Journal:  Case Rep Nephrol       Date:  2012-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.